Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Bridge to Life is a leading supplier of commercialized organ preservation solutions and machine perfusion systems. Its products are widely used by transplant centers and organ procurement organizations globally. The company has achieved milestones in advancing hypothermic oxygenated perfusion technology for improved outcomes in liver transplantation. Clinical results include successful global adoption of its HOPE technology and Vitasmart system for better donor organ viability.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Bridge to Life.